India Lifts Export Ban on Remdesivir and Its Component API

India's Directorate General of Foreign Trade moved its export policy for COVID-19 treatment drug remdesivir and its active pharmaceutical ingredient from “prohibited” to “restricted” in a June 14 notification. The export of the drug or its API against the drug's advance authorizations will no longer need a separate authorization, the release said.